Newsweek

‘Deadly Risk’ of Fat-Loss Drugs

“MIRACLE” FAT-MELTING DRUG OZEMPIC HAS been linked in a study to a series of rare but potentially fatal psychiatric episodes, scientists have warned.

The injectable prescription drug was developed to manage blood sugar levels in patients with Type 2 diabetes, but it has gained popularity and gone viral on social media due to one sought-after side effect: weight loss.

Ozempic is based on a naturally occurring human hormone called glucagon-like peptide 1, which plays an important role in regulating appetite and blood sugar levels. Its active ingredient is a molecule called semaglutide, which mimics the structure of this GLP-1 hormone and activates its receptors.

In doing so, semaglutide induces feelings of fullness while delaying the emptying of our stomach, making us less hungry and therefore less likely to overeat.

Semaglutide is also

You’re reading a preview, subscribe to read more.

More from Newsweek

Newsweek4 min read
Five Ways to Keep Your Dog Healthy
We want our beloved dogs to live a long life, but also a healthy one—not least to keep the bills down. The American Kennel Club reported that the average lifespan of small dog breeds is between 10 to 15. The beagle, a popular breed, has an average li
Newsweek4 min read
Wildlife Crossings Are a Bear Necessity
A MOOSE, A DEER AND A FOX walk into a tunnel. It might sound like the setup for a joke, but it’s a scene that wildlife ecologist Patricia Cramer captured while studying how animals use wildlife crossings. “This bull moose comes into the culvert in th
Newsweek4 min read
We’re Struggling to Afford Our Furry Friends
THEY’RE OUR BEST FRIENDS, part of the family and a source of endless comfort, joy and laughter, but pets are also becoming increasingly pricey companions for Americans. A majority of 72 percent of pet owners responding to an exclusive Redfield & Wilt

Related Books & Audiobooks